Increasing numbers of older US men with prostate cancer are undergoing treatments that carry risks of side effects that can ...

At the same time, aggressive treatment declined in men with low-risk prostate cancer as might have been expected in an era ...

Researchers conducted a cohort study to try to characterize long-term treatment-related adverse effects and complications in ...

Men who undergo prostate cancer treatment face a greatly increased risk of life-altering, long-term complications, a new ...

“Use of active surveillance has increased over the last 15 years for men with low-risk prostate cancer, and it is now the ...

Metastatic castration-resistant prostate cancer (mCRPC) is a severe form of late-stage disease where the tumor can no longer ...

A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve ...

Prostate cancer is a growing problem in men, and advanced cases are rising for the first time in 20 years, which is why ...

Researchers have found an association between baseline circulating tumor cell count and survival in metastatic ...

Panelists discuss how implementing targeted strategies can promote equity in treatment for all patients, while offering ...

Men who undergo prostate cancer treatment face a greatly increased risk of life-altering, long-term complications, a ...